180 Life Sciences Beta
¿Qué es el Beta de 180 Life Sciences?
El Beta de 180 Life Sciences Corp. es 0.35
¿Cuál es la definición de Beta?
BETA indica si una acción es más o menos volátil que el mercado en su conjunto. Una beta inferior a 1 indica que el stock es menos volátil que el mercado, mientras que una beta más de 1 indica que el stock es más volátil. La volatilidad se mide como la fluctuación del precio alrededor de la media.
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
Beta de compañías en Sector Health Care en NASDAQ en comparadas con 180 Life Sciences
¿Qué hace 180 Life Sciences?
180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of novel drugs for unmet medical needs in chronic pain, inflammation, inflammatory diseases, and fibrosis. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and anti-tumour necrosis factor (Anti-TNF) platform, which focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.
Empresas con beta similar a 180 Life Sciences
- Goldlion tiene Beta de 0.35
- AEON Credit Service (Asia) tiene Beta de 0.35
- Invitrocue tiene Beta de 0.35
- Marsh & McLennan Cos tiene Beta de 0.35
- Enzo Biochem tiene Beta de 0.35
- North European Oil Royalty Trust tiene Beta de 0.35
- 180 Life Sciences tiene Beta de 0.35
- Huanxi Media tiene Beta de 0.35
- China ITS () Co tiene Beta de 0.35
- United Utilities Plc tiene Beta de 0.35
- Ameriserv Inc tiene Beta de 0.35
- American Equity Investment Life Co tiene Beta de 0.35
- Peoples Bancorp Of North Carolina Inc tiene Beta de 0.35